Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Accepts healthy volunteers Results available

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection

ClinicalTrials.gov ID: NCT01887912

Public ClinicalTrials.gov record NCT01887912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy, Immunogenicity, and Safety Study of Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection (Cdiffense™)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study was to evaluate the efficacy of the Clostridium difficile vaccine to prevent primary symptomatic C. difficile infection (CDI) in participants at risk for CDI where there is a substantial unmet medical need. Primary objective: * To assess the efficacy of the C. difficile vaccine in preventing the onset of symptomatic primary CDI confirmed by polymerase chain reaction (PCR) in adult participants aged \>= 50 years who are at risk for CDI and have received at least 1 injection. Secondary Objectives: Efficacy: * To assess prevention of symptomatic PCR-confirmed primary CDI cases after 3 injections administered at 0, 7, and 30 days. * To assess prevention of symptomatic PCR-confirmed primary CDI cases after completion of at least 2 injections. Immunogenicity: * To describe the immunogenicity to toxin A and toxin B at specific time points in a subset of participant and in participants with CDI at Day 0 and Day 60. Safety: * To describe the safety profile of all participants who received at least 1 injection.

Study identification

NCT ID
NCT01887912
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
9,302 participants

Conditions and interventions

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2013 (Actual)
Primary completion
Jun 12, 2018 (Actual)
Completion
Jun 12, 2018 (Actual)
Last update posted
Mar 28, 2022

2013 – 2018

United States locations

U.S. sites
142
U.S. states
37
U.S. cities
127
Facility City State ZIP Site status
Not listed Huntsville Alabama 35803 —
Investigational Site 104 Mobile Alabama 36608 —
Not listed Flagstaff Arizona 86001 —
Investigational Site 194 Phoenix Arizona 85018 —
Investigational Site 503 Surprise Arizona 85374 —
Not listed Little Rock Arkansas 72205 —
Not listed Bakersfield California 93301 —
Not listed Banning California 92220 —
Not listed Garden Grove California 92844 —
Not listed La Mesa California 91942 —
Investigational Site 534 Los Angeles California 90022 —
Investigational Site 051 Los Angeles California 90027 —
Not listed Modesto California 95350 —
Not listed Redding California 96001 —
Not listed Sacramento California 95817 —
Investigational Site 504 Simi Valley California 93065 —
Investigational Site 057 Stanford California 94305 —
Investigational Site 176 Upland California 91786 —
Not listed Ventura California 93003 —
Investigational Site 546 Wheat Ridge Colorado 90033 —
Not listed Bristol Connecticut 06010 —
Not listed Danbury Connecticut 06810 —
Investigational Site 143 Bradenton Florida 34209 —
Investigational Site 187 Brandon Florida 33511 —
Investigational Site 075 Clearwater Florida 33756 —
Investigational Site 517 Clearwater Florida 33765 —
Investigational Site 055 Crystal River Florida 34429 —
Not listed DeLand Florida 32720 —
Investigational Site 506 Gainesville Florida 32607 —
Investigational Site 099 Hialeah Florida 33012 —
Investigational Site 009 Jacksonville Florida 32216 —
Not listed Lauderdale Lakes Florida 33319 —
Not listed Miami Florida 33165 —
Not listed Orange Park Florida 32073 —
Investigational Site 112 Pensacola Florida 32504 —
Not listed Port Saint Lucie Florida 34987 —
Investigational Site 088 Sarasota Florida 34239 —
Investigational Site 040 St. Petersburg Florida 33709 —
Investigational Site 114 St. Petersburg Florida 33713 —
Not listed Tamarac Florida 33321 —
Not listed Tampa Florida 33612 —
Not listed West Palm Beach Florida 33401 —
Investigational Site 149 Augusta Georgia 30912 —
Investigational Site 529 Decatur Georgia 30030 —
Not listed Macon Georgia 31201 —
Investigational Site 010 Savannah Georgia 31406 —
Investigational Site 049 Idaho Falls Idaho 83494 —
Investigational Site 543 Pocatello Idaho 83201 —
Not listed Evanston Illinois 60201 —
Not listed Peoria Illinois 61602 —
Not listed Peoria Illinois 61614 —
Not listed Anderson Indiana 46011 —
Investigational Site 101 Iowa City Iowa 52242 —
Not listed Topeka Kansas 66606 —
Not listed Louisville Kentucky 40202 —
Investigational Site 091 Metairie Louisiana 70006 —
Investigational Site 084 New Orleans Louisiana 70121 —
Not listed Opelousas Louisiana 70570 —
Investigational Site 077 Shreveport Louisiana 71101 —
Not listed Auburn Maine 04210 —
Not listed Baltimore Maryland 21224 —
Investigational Site 002 Boston Massachusetts 02215 —
Investigational Site 035 West Roxbury Massachusetts 02132 —
Investigational Site 190 Ann Arbor Michigan 48106 —
Investigational Site 175 Detroit Michigan 48202 —
Investigational Site 183 Flint Michigan 48504 —
Not listed Grosse Pointe Woods Michigan 48236 —
Not listed Kalamazoo Michigan 49007 —
Not listed Livonia Michigan 48152 —
Investigational Site 069 Royal Oak Michigan 48073 —
Not listed Stevensville Michigan 49127 —
Not listed Troy Michigan 48098 —
Not listed Butte Montana 59701 —
Investigational Site 189 Hillsborough New Jersey 8844 —
Investigational Site 044 Neptune City New Jersey 07753 —
Not listed Teaneck New Jersey 07666 —
Not listed Albuquerque New Mexico 27103 —
Not listed Albuquerque New Mexico 87102 —
Investigational Site 022 Endwell New York 13760 —
Not listed Rochester New York 14621 —
Not listed Rochester New York 14642 —
Not listed Syracuse New York 13210 —
Not listed The Bronx New York 10467 —
Investigational Site 013 The Bronx New York 10468 —
Investigational Site 146 Asheville North Carolina 28805 —
Not listed Cary North Carolina 27518 —
Not listed Charlotte North Carolina 28209 —
Not listed Hickory North Carolina 28602 —
Not listed Raleigh North Carolina 27612 —
Not listed Raleigh North Carolina 48202 —
Not listed Statesville North Carolina 28625 —
Not listed Wilmington North Carolina 28401 —
Not listed Winston-Salem North Carolina 27103 —
Investigational Site 031 Fargo North Dakota 58104 —
Not listed Fargo North Dakota 58122 —
Investigational Site 523 Canton Ohio 44710 —
Not listed Cincinnati Ohio 45219 —
Not listed Cleveland Ohio 44106 —
Investigational Site 129 Cleveland Ohio 44109 —
Not listed Cleveland Ohio 44118 —
Investigational Site 003 Columbus Ohio 43215 —
Investigational Site 061 Dayton Ohio 45419 —
Not listed Dayton Ohio 45428 —
Not listed Kettering Ohio 45429 —
Not listed Marion Ohio 43302 —
Investigational Site 095 Middletown Ohio 45005 —
Not listed Bend Oregon 97701 —
Investigational Site 528 Camp Hill Pennsylvania 17011 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19140 —
Not listed Pittsburgh Pennsylvania 15212 —
Not listed Pittsburgh Pennsylvania 15240 —
Investigational Site 083 Uniontown Pennsylvania 15401 —
Not listed West Reading Pennsylvania 19611 —
Investigational Site 020 Wilkes-Barre Pennsylvania 18711 —
Investigational Site 050 Pawtucket Rhode Island 02860 —
Not listed Providence Rhode Island 02906 —
Not listed Providence Rhode Island 02908 —
Investigational Site 540 Charleston South Carolina 29407 —
Investigational Site 047 Mt. Pleasant South Carolina 29464 —
Investigational Site 180 Spartanburg South Carolina 29303 —
Investigational Site 086 Rapid City South Dakota 57701 —
Not listed Franklin Tennessee 37067 —
Not listed Jackson Tennessee 38305 —
Not listed Nashville Tennessee 37082 —
Not listed Nashville Tennessee 37203 —
Investigational Site 544 Austin Texas 78726 —
Not listed Corpus Christi Texas 78413 —
Investigational Site 006 Dallas Texas 75216 —
Investigational Site 119 Fort Worth Texas 76104 —
Not listed Groesbeck Texas 76642 —
Investigational Site 193 San Antonio Texas 78229 —
Not listed Tomball Texas 77375 —
Investigational Site 135 Orem Utah 84058 —
Investigational Site 080 Salt Lake City Utah 84124 —
Investigational Site 012 Lynchburg Virginia 24501 —
Not listed Williamsburg Virginia 23185 —
Investigational Site 196 Winchester Virginia 22601 —
Not listed Spokane Washington 99202 —
Not listed Tacoma Washington 98405 —
Investigational Site 030 Marshfield Wisconsin 54449 —
Not listed Weston Wisconsin 54476 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 193 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01887912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01887912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →